Cocoon Biotech Inc. — Form D
Cocoon Biotech Inc. of Mansfield, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-12-13. The offering totals $1000K, of which $385K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-12-13
- Form: D
- Accession: 0001611264-21-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1000K
- Amount sold: $385K
- Remaining: $615K
- Investors: 6
- Date of first sale: 2021-08-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-424719
Issuer
- Name: Cocoon Biotech Inc.
- CIK: 0001611264
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 241 Francis Avenue, Mansfield, MA, 02048
- Phone: 617-356-7346
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Annalisa Jenkins | Director | Dallas, TX |
| Charles Koppel | Director | Mansfield, MA |
| Mary Thistle | Director | CAMBRIDGE, MA |
| Ailis Tweed-Kent | Director | Mansfield, MA |
| Ailis Tweed-Kent | Executive Officer | Mansfield, MA |
| Grace Colon | Director | NEWARK, CA |
Other filings by this issuer (5)
More